GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE MKT: SENS), a medical technology company focused on the design, development and commercialization of glucose monitoring products designed to help people with diabetes confidently live their lives with ease, will ring The Opening Bell® at the New York Stock Exchange (NYSE) on Wednesday, March 23, 2016. The company began trading on NYSE MKT on March 18, 2016.
“Senseonics is proud to ring The Opening Bell on behalf of our entire team and investors to celebrate our recent listing on NYSE MKT. Our listing represents an important step for the company to realize its vision of delivering a long-term, accurate sensor for the millions of people with diabetes,” said Timothy T. Goodnow, President and CEO of Senseonics. “The NYSE is a world-class platform for growth-stage medical device companies, and we look forward to a strong future on the exchange.”
Dr. Goodnow will be joined by several members of the management team as he rings The Opening Bell at 9:30 a.m. EDT on March 23, 2016. A live feed of the NYSE Opening Bell® (9:26 a.m. EDT) can be found at http://new.livestream.com/NYSE. Photos and video of the NYSE bell ringing will also be available, courtesy of the NYSE, on Facebook (NYSE), Twitter (@NYSE) and Instagram (@NYSE).
About Senseonics
Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Our first generation continuous glucose monitoring (CGM) system, Eversense, includes a small sensor, smart transmitter and mobile application. Based on fluorescence sensing technology, the sensor is designed to be inserted subcutaneously and communicate with the smart transmitter to wirelessly transmit glucose levels to a mobile device. After insertion, the sensor is designed to continually and accurately measure glucose levels. For more information on Senseonics, please visit www.senseonics.com.
